This suggests that the effects of TZD on growth, proliferation and adipogenesis seen within the entire tumor cell population are specifically attributable to the cancer stem cell fraction which expresses higher levels of PPARγ and that TZD treatment reduces the proportion of CSCs in the tumor population. The gene discussed is PPARG; the disease is neoplasm.